Form SC 13D/A
TEVA PHARMACEUTICAL INDUSTRIES LTD filed this Form SC 13D/A on 11/13/2017
Document Outline
Entire Document (369.9 KB)
Subdocument 1 - SC 13D/A - SC 13D/A
Page 1 - SECURITIES AND EXCHANGE COMMISSION
Page 2 - 13D
Page 3 - 13D
Page 4 - 13D
Page 5 - 13D
Page 6 - 13D
Page 7 - Amendment
Page 8 - Margin Loan
Page 9 - N/A
Page 10 - SIGNATURES
Page 11 - Schedule I
Page 12 - N/A
Page 13 - N/A
Page 14 - Citizenship:
Page 15 - INDEX TO EXHIBITS
Subdocument 2 - EX-99.1 - EX-99.1
Page 1 - Exhibit 1
Subdocument 3 - EX-99.4 - EX-99.4
Page 1 - Exhibit 4
Page 2 - Valuation:
Page 3 - N/A
Page 4 - Settlement Terms:
Page 5 - Extraordinary Events:
Page 6 - Additional Disruption Events:
Page 7 - Additional Termination Event.
Page 8 - Acquisition Transaction Announcement
Page 9 - Replacement DR
Page 10 - provided
Page 11 - Additional Representations, Warranties and Agreements of Counterparty
Page 12 - provided
Page 13 - Acknowledgments.
Page 14 - Schedule Provisions
Page 15 - Right to Extend
Page 16 - Permitted Contact
Page 17 - Code
Page 18 - Waiver of Jury Trial
Page 19 - Reportable transaction.
Page 20 - N/A
Page 21 - Exhibit 4
Page 22 - EXHIBIT A
Page 23 - N/A
Page 24 - EXHIBIT B
Page 25 - GUARANTY
Page 26 - Section
Page 27 - Section 5. Miscellaneous.
Page 28 - N/A
Page 29 - ANNEX A
Page 30 - First Lien
Page 31 - Restrictive Condition
Page 32 - The Security Interests
Page 33 - Administration of the Collateral and Valuation of the Securities
Page 34 - plus
Page 35 - Remedies upon Events of Default with respect to Counterparty
Page 36 - Replacement Custodian
Page 37 - Intercreditor Agreement
Page 38 - N/A